SETD2 and gastric cancer: A recent study showed that high SETD2 (SET domain-containing protein 2, also known as HYPB) expression was correlated with better prognosis for GC patients, and its overexpression in GC cell lines significantly inhibits cell proliferation, migration, and invasion (5).